InvestorsHub Logo
Post# of 253400
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 83027

Monday, 08/31/2009 8:39:04 AM

Monday, August 31, 2009 8:39:04 AM

Post# of 253400
AZN’s Brilinta
One note regarding the PLATO study: in the U.S patients subgroup, which was only about 10% of patients in the study, there was a 25% higher chance for CV event for those on Brilinta than for those on Plavix.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.